A Multicenter Phase 1B Study of Ceritinib plus Nivolumab in Patients with ALK+NSCLC P1.01-085 (ID 1323)
Invited conference paper presented and published in conference proceedings

香港中文大學研究人員

其它資訊
著者SHAW A, LOONG Herbert Ho Fung, TAN D S, GRISCTI K, GAO H, FINCKENSTEIN F, SCOTT J, VANSTEENKISTE J
會議名稱16th World Conference on Lung Cancer
會議開始日06.09.2015
會議論文集題名16th World Conference on Lung Cancer
詳細描述organized by International Association for the Study of Lung Cancer,
出版年份2015
月份9
頁次P1.01 Poster session/ Treatment of Advanced Diseases--NSCLC (ID 206)
語言英式英語
關鍵詞ALK; NSCLC

上次更新時間 2018-18-01 於 22:54